The generic names of some drugs were omitted from the original supplemental data. The error has been corrected in the online data supplement.
© 2020 by The American Society of Hematology
2020
Skip Nav Destination
ERRATUM|
January 7, 2020
Goldmann L, Duan R, Kragh T, et al. Oral Bruton tyrosine kinase inhibitors block activation of the platelet Fc receptor CD32a (FcγRIIA): a new option in HIT? Blood Adv. 2019;3(23):4021-4033.
Blood Adv (2020) 4 (1): 112.
Article history
Submitted:
December 16, 2019
Accepted:
December 16, 2019
